Stay updated on Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial
Sign up to get notified when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.

Latest updates to the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page
- Check3 days agoChange DetectedFooter now displays Revision: v3.3.3; the HHS Vulnerability Disclosure link and the Revision: v3.3.2 reference were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedRevision: v3.3.2 has been added. The previous Revision: v3.3.1 is replaced on the page.SummaryDifference0.1%

- Check31 days agoChange DetectedPublications section now states that entries are automatically filled from PubMed and the page revision is shown as v3.3.1, replacing the previous text that referenced v3.2.0.SummaryDifference0.1%

- Check39 days agoChange DetectedRemoved the government funding status notice from the page, eliminating information about funding-related updates and delays. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check53 days agoChange DetectedScreenshots show only minor formatting/layout updates to the Study Details page with no changes to core data such as eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check82 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference3%

Stay in the know with updates to Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dolutegravir for Initial HIV in Resource-limited Settings Clinical Trial page.